-
India likely to approve authorise COVID-19 vaccines in weeks
expresspharma
December 09, 2020
Government has identified 300 million people, including healthcare workers, policemen, and citizens above the age of 50, who would be administered a vaccine on a priority basis.
-
HSMD seeks update from government on Pfizer’s COVID-19 vaccine to prepare for distribution
expresspharma
December 09, 2020
The Hindustan Syringes and Medical Devices (HSMD) has written a letter to the Department of Health & Family Welfare requesting an update about the government’s action plans for Pfizer’s COVID-19 vaccine in India.
-
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
prnasia
December 08, 2020
PostEra announced a strategic partnership with Pfizer Inc. with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry.
-
Pfizer seeks EUA for COVID-19 vaccine in India
expresspharma
December 07, 2020
Pfizer has written to the Drugs Controller General of India, applying for emergency use authorisation (EUA) of its coronavirus vaccine in India, the first to do so, CNN-News18 reported citing a government source.
-
Pfizer-BioNTech COVID-19 vaccine gets EUA approval from the UK
expresspharma
December 03, 2020
Care home residents, health and care staff, the elderly and people who are clinically extremely vulnerable will be first in line.
-
Evaluating Pfizer vaccine for possible listing for emergency use: WHO
expresspharma
December 03, 2020
WHO is in discussions with MHRA for accessing some of information from their assessment which may expedite WHO’s emergency listing.
-
Pfizer-BioNTech can use UK as test bed for cold chain distribution: GlobalData
expresspharma
December 03, 2020
The country’s small size, dense population and strong healthcare infrastructure should mean distribution of the vaccine with cold chain should go smoothly.
-
Pfizer, BioNTech Submit CMA for COVID-19 Vaccine
americanpharmaceuticalreview
December 02, 2020
Pfizer and BioNTech have submitted a formal Application for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA) for their mRNA vaccine candidate, BNT162b2, against COVID-19.
-
Covid-19 vaccine distribution– A daunting task, but there is a way out
expresspharma
November 30, 2020
The unprecedented pandemic and the havoc wrecked by COVID-19 have brought the leaders of scientific community all over the world together and the sharpest of the minds have been relentlessly working towards a solution to address this.
-
Half of top 20 global innovative pharma companies MCap reported positive growth in Q3 2020- GlobalData
expresspharma
November 27, 2020
Half of the companies in a ranking of top 20 global innovative pharmaceutical firms by data and analytics company GlobalData reported positive market capitalization (MCap) growth in Q3, with Pfizer and Daiichi Sankyo Co reporting double-digit percentage..